At ASCO, the Cancer Community Hyped the Wrong Trial
Oncologist Bishal Gyawali, MD, PhD, highlights concerns surrounding which trials the oncology community is choosing to celebrate.
Related Articles
The left shouldn’t fear nationalism. It should embrace it.
National solidarity is an old, powerful theme on the left — one it shuns at its peril.
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial | Journal of Clinical Oncology
PURPOSEThe CLL12 trial reassesses the watch-and-wait consensus for early-stage chronic lymphocytic leukemia (CLL) in the context of targeted therapies.METHODSThe German CLL Study Group conducted a…
‘A national disgrace’: A quarter of households with children under four don’t have enough food
The Education Policy Institute has warned children under five are more likely to experience food poverty than older children.
Inequality control • Resolution Foundation
The turbulent 2020s have had profound implications for household wealth in Britain: lockdowns pushed saving to unprecedented highs, asset prices surged and then tanked, and…
How Social Determinants of Mental Health Increase Depression Risk
In her debut blog, Ayana Cant summarises an umbrella review exploring the impact of social determinants of mental health on risk of depression.
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia | NEJM
Obecabtagene autoleucel (obe-cel) is an autologous 41BB-ζ anti-CD19 chimeric antigen receptor (CAR) T-cell therapy which uses an intermediate-affinity CAR to reduce toxic effects and improve…
A public defender’s fight against brain cancer
Brown University Health used advanced laser technologies to fight Alves’ glioblastoma.
Monitor de Reputación Sanitaria Servicios hospitalarios
Monitor Empresarial de Reputación Corporativa
New Data: The Most Promising Treatments for Long COVID
A collection of common and new medications is showing good results against the constellation of symptoms that individualize long COVID. Here’s the latest.
Long wait for NHS mental healthcare has ‘stark consequences for children’s life chances’
Consultant psychiatrist on why early intervention is key and why delays are unacceptable